Search for mutations in signaling pathways in head and neck squamous cell carcinoma

Thais Gulim De Carvalho1, Ana Carolina De Carvalho, Danielle Calheiros Campelo Maia

  • 1Cancer Molecular Biology Laboratory, Department of Science Biology, Federal University of São Paulo (UNIFESP), 04039-032, São Paulo, SP, Brazil.

Oncology Reports
|May 15, 2013
PubMed

Insights

Mutations in key cancer-related genes like KRAS, BRAF, PIK3CA, JAK1, and JAK2 are rare in head and neck squamous cell carcinoma (HNSCC). This study found no mutations in these genes in 94 HNSCC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Mutations in Janus kinase-STAT (JAK-STAT) signaling pathway genes are linked to hematological tumors.
  • The PIK3CA, BRAF, and KRAS genes have been identified in a subset of head and neck squamous cell carcinoma (HNSCC) cases.
  • The mutation status of MAPK, PI3K-AKT, and JAK-STAT pathways in HNSCC remains largely uninvestigated.

Purpose of the Study:

  • To determine the mutation status of genes within the MAPK, PI3K-AKT, and JAK-STAT signaling pathways in HNSCC.
  • To investigate the prevalence of mutations in KRAS, BRAF, PIK3CA, JAK1, and JAK2 in HNSCC.
  • To assess the potential role of these kinase gene mutations in HNSCC development.

Main Methods:

  • Direct DNA sequencing analysis was performed on cDNA synthesized from RNA extracted from 94 HNSCC patient tumor cells.
  • Evaluated mutations in KRAS, BRAF, PIK3CA, JAK1, and JAK2 genes.
  • Identified known polymorphisms in JAK1 and JAK2 genes.

Main Results:

  • All 94 HNSCC patients analyzed presented with wild-type KRAS, BRAF, and PIK3CA genes.
  • No mutations were detected in JAK1 or JAK2 genes, although several known polymorphisms were identified.
  • The study found no evidence of mutations in the investigated kinase genes within the HNSCC cohort.

Conclusions:

  • Mutations in KRAS, BRAF, PIK3CA, JAK1, and JAK2 appear to be infrequent in head and neck squamous cell carcinoma.
  • The investigated kinase signaling pathways may not be major drivers of tumorigenesis in the majority of HNSCC cases.
  • Further research may be warranted to explore other genetic alterations in HNSCC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...